Key Market Indicator:
F&G: 40
25.233,35 NASDAQ · 48.573,00 DOW · 6.841,40 S&P · 4.299,43 Gold · 61,01 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© ACCESSWIRE
11.12.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv
News Preview
The collaboration highlights Zomedica's commitment to expanding pet wellness education as Assisi Loop technology is featured in the highly anticipated movie Merv now available on Prime Video ANN ARBOR, MI / ACCESS Newswire / December 11, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.12.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
News Preview
Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN ARBOR, MI / ACCESS Newswire / December 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and t...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.11.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
News Preview
November session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars ANN ARBOR, MI / ACCESS Newswire / November 11, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices f...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ACCESSWIRE
06.11.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential
News Preview
Certification enhances global market readiness, reinforces quality systems, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire / November 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic devic...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ACCESSWIRE
04.11.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
News Preview
Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire / November 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering point-of-care diagnostic and therapeutic products for equine and companion a...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
News Preview
Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's leadership in targeted tPEMF innovation ANN ARBOR, MI / ACCESS Newswire / October 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"),...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union
News Preview
Expanded agreement strengthens Zomedica's European presence, broadens product portfolio on the market, and positions the Company to capture growth in the multi-billion-dollar global veterinary diagnostics and therapeutic device markets ANN ARBOR, MI, MI / ACCESS Newswire / October 14, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar
News Preview
Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities ANN ARBOR, MI, MI / ACCESS Newswire / October 9, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative po...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.09.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay
News Preview
First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients ANN ARBOR, MI / ACCESS Newswire / September 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
18.09.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents
News Preview
Intellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the rapidly growing multi-billion dollar veterinary diagnostics market ANN ARBOR, MI / ACCESS Newswire / September 18, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
12.09.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary Imaging
News Preview
Cutting-Edge Digital Microscopy System Featured in Monthly Series Showcasing Innovation in Veterinary Care ANN ARBOR, MI / ACCESS Newswire / September 12, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for companion and equine...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.09.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica and UXR Announce Expanded Distribution Agreement in Canada
News Preview
Agreement strengthens Canadian veterinarians' access to Zomedica's advanced therapeutic and monitoring solutions ANN ARBOR, MI / ACCESS Newswire / September 10, 2025 / Zomedica Corp. (OTCQB:ZOMDF), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, announced today that it has exp...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ACCESSWIRE
03.09.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio
News Preview
Strategic partnership with Pioneer Veterinary Products Limited expands Zomedica's presence in the UK veterinary market through distribution of its leading point-of-care solutions ANN ARBOR, MI / ACCESS Newswire / September 3, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices
News Preview
New agreement brings innovative shock wave, tPEMF therapy, monitoring, and bleeding control solutions to more than 2,200 member clinics nationwide ANN ARBOR, MI / ACCESS Newswire / August 19, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeuti...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
12.08.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine
News Preview
Revolutionary Plant-Based Technology Gains Momentum as a Game-Changer in Wound Management ANN ARBOR, MI / ACCESS Newswire / August 12, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for equine and companion animals, is pleased...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.08.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
News Preview
Zomedica posts record year-over-year revenue for 18th straight quarter! ANN ARBOR, MI / ACCESS Newswire / August 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidate...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.07.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets
News Preview
Breakthrough tPEMF™ Technology Showcased in Monthly Series Exploring Innovation in Veterinary Care ANN ARBOR, MI / ACCESS Newswire / July 16, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for companion and equine animals...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.07.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala
News Preview
Elevating Equine Health and Show Experience with Leading Shock Wave Therapy ANN ARBOR, MI / ACCESS Newswire / July 10, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced a strat...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.06.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope
News Preview
Intellectual Property Portfolio grows to 221 Patents and 140 Trademarks ANN ARBOR, MI / ACCESS Newswire / June 24, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the issuan...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.06.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics
News Preview
Next-Generation Diagnostic Platform Takes Center Stage in Monthly Series Showcasing Innovation in Veterinary Care ANN ARBOR, MI / ACCESS Newswire / June 19, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine a...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
21.05.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution
News Preview
The TRUFORMA Platform now has the widest dynamic range (without manual dilution) available either at the Point of Care or from a Reference Lab ANN ARBOR, MI / ACCESS Newswire / May 21, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.05.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations
News Preview
Engaging Sessions to Highlight Game-Changing Technologies, Expert Insights, and Growth Opportunities in Animal Health Featuring Zomedica Products ANN ARBOR, MI / ACCESS Newswire / May 19, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeut...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.05.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth
News Preview
ANN ARBOR, MI / ACCESS Newswire / May 15, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the first quarter ended March 31, 2025."We ar...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.05.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy
News Preview
Innovative Registry Harnesses Shock Wave Therapy to Advance Non-Drug Equine Asthma Treatment and Drive Evidence-Based Veterinary Care ANN ARBOR, MI / ACCESS Newswire / May 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.05.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET
News Preview
ANN ARBOR, MI / ACCESS Newswire / May 9, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to disc...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.03.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth
News Preview
ANN ARBOR, MI / ACCESS Newswire / March 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the fourth quarter and year-ended December 31, 2...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.03.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Corp. Announces Transition to OTCQB Venture Market
News Preview
Zomedica's ticker symbol will change to ZOMDF ANN ARBOR, MI / ACCESS Newswire / March 4, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a leading veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced that its common shares...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.02.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET
News Preview
ANN ARBOR, MI / ACCESS Newswire / February 26, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, March 13, 2025, at 4:30 p...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
12.02.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters
News Preview
Relocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually ANN ARBOR, MI / ACCESS Newswire / February 12, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and compan...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.02.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis
News Preview
Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, 2025 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic devices for equine and companion animals, today announced a groundbr...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
07.01.2025
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
News Preview
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today a...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.12.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
News Preview
With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform ANN ARBOR, MI / ACCESSWIRE / December 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and th...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.12.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer
News Preview
Seasoned executive brings a broad skill set to Zomedica's leadership team ANN ARBOR, MI / ACCESSWIRE / December 19, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointe...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.11.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024
News Preview
ANN ARBOR, MI / ACCESSWIRE / November 27, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that its Chief Executive Officer, Larry Heaton, will present and host one-on-...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.11.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform
News Preview
Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI / ACCESSWIRE / November 14, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
12.11.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Noble Capital Markets Initiates Equity Research Coverage on Zomedica
News Preview
ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company. The full report by N...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
08.11.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024
News Preview
ANN ARBOR, MI / ACCESSWIRE / November 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will present and host one-on-one m...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
07.11.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
News Preview
ANN ARBOR, MI / ACCESSWIRE / November 7, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the third quarter ended September 30, 2024.&q...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.10.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform
News Preview
New Ear Cytology protocol significantly improves veterinary practice workflow by reducing total time to perform common diagnostic procedure / ACCESSWIRE / October 24, 2024 / ANN ARBOR, MI / ACCESSWIRE / October 24, 2024/ Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering poin...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET
News Preview
ANN ARBOR, MI / ACCESSWIRE / October 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, November 7, 2024, at 4:30 p.m....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.10.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference
News Preview
Leading veterinary experts to present educational programs featuring Zomedica product applications at the Fetch dvm360 Veterinary Conference ANN ARBOR, MI / ACCESSWIRE / October 15, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeut...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.10.2024
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe
News Preview
Expansion adds new countries to Grovet's existing PulseVet distribution coverage and enables launch of the TRUFORMA® equine platform in Europe ANN ARBOR, MI / ACCESSWIRE / October 3, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and th...
Themefolio
Profiler
Peergroup
© Newsfile
27.09.2023
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica, Inc. to Present at the LD Micro Main Event XVI
News Preview
Presentation on Tuesday, October 3rd at 1:00 PM PTAnn Arbor, Michigan--(Newsfile Corp. - September 27, 2023) - Zomedica Corp. (NYSE American: ZOM) (the "Company") announced today that the Company is scheduled to provide a strategic overview and its prospects for growth during the LD Micro Main Event XVI Conference from October 3-5, 2023 at the Luxe...
Themefolio
Profiler
Peergroup
© Newsfile
09.08.2022
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Corp. to Present at Investor Summit Group's Q3 Virtual Conference
News Preview
Ann Arbor, Michigan--(Newsfile Corp. - August 9, 2022) - Zomedica Corp. (NYSE American: ZOM) today announced that Larry Heaton, CEO, will be attending the Q3 Virtual Investor Summit. During the presentation, Zomedica Chief Executive Officer, Larry Heaton, will highlight the Company's recent acquisitions and integration of PulseVet and the assets of...
Themefolio
Profiler
Peergroup
© Newsfile
28.02.2022
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
Zomedica Announces Participation in the Q1 Virtual Investor Summit
News Preview
Ann Arbor, Michigan--(Newsfile Corp. - February 28, 2022) - Zomedica (AMEX: ZOM) today announced that Larry Heaton, CEO will be attending the Q1 Virtual Investor Summit. During the presentation, Zomedica’s Chief Executive Officer, Larry Heaton, will highlight the Company's recent integration of PulseVet, Inc., it's progress with the TRUFORMA...
Themefolio
Profiler
Peergroup
© Newsfile
25.06.2020
ISIN: CA98980M1095

Zomedica Corporation
ZOM

LISTED

XASE
PCG Research Announces Publication of Update Report Covering Zomedica Pharmaceuticals Corp.
News Preview
Diagnostic Commercialization Activities for the Companion Animal Market ApproachingNew York, New York--(Newsfile Corp. - June 25, 2020) - PCG Research, the equity research division of PCG Advisory, Inc., a leading investor relations and strategic advisory firm based in New York City focused on small and micro-cap public companies, today announced i...
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2025 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 13.12.2025, Calendar Week 50, 347th day of the year, 18 days remaining until EoY.